Topics: Value-Driven Health Care, Policy Solutions, The Value Collaborative
From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results.
lg_1000x775_value-collaborative-no-tag.
As part of PhRMA’s efforts to explore policy solutions to promote value-driven health care, we recently participated in a forum convened by Deloitte and the Network for Excellence in Health Innovation, which also included leaders from plans, health providers, academia, patient groups, non-profits and the medical device industry, to discuss how a value-driven health care system can be built in a way that supports innovation.
Several recommendations were discussed, which would allow evolution of the competitive, private health care market to become increasingly driven by value.
Read the full white paper summarizing these recommendations here.
Topics: Value-Driven Health Care, Policy Solutions, The Value Collaborative
Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004
Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."